69 related articles for article (PubMed ID: 2688344)
21. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
[TBL] [Abstract][Full Text] [Related]
22. Natural killer cell function and modulation by alpha IFN and IL2 in AIDS patients and prodromal subjects.
Lew F; Tsang P; Solomon S; Selikoff IJ; Bekesi JG
J Clin Lab Immunol; 1984 Jul; 14(3):115-21. PubMed ID: 6237206
[TBL] [Abstract][Full Text] [Related]
23. Generation of suppressor cells for natural killer activity in cancer patients after surgery.
Uchida A; Kolb R; Micksche M
J Natl Cancer Inst; 1982 May; 68(5):735-41. PubMed ID: 6461792
[TBL] [Abstract][Full Text] [Related]
24. Systemic administration of human leukocyte interferon to melanoma patients. III. Increased helper:suppressor cell ratios in melanoma patients during interferon treatment.
Karavodin LM; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(4):193-202. PubMed ID: 6241293
[TBL] [Abstract][Full Text] [Related]
25. Limited effect of eicosapentaenoic acid on T-lymphocyte and natural killer cell numbers and functions in healthy young males.
Miles EA; Banerjee T; Wells SJ; Calder PC
Nutrition; 2006 May; 22(5):512-9. PubMed ID: 16600816
[TBL] [Abstract][Full Text] [Related]
26. Abdominal surgical interventions: local and systemic consequences for the immune system--a prospective study on elective gastrointestinal surgery.
Decker D; Tolba R; Springer W; Lauschke H; Hirner A; von Ruecker A
J Surg Res; 2005 Jun; 126(1):12-8. PubMed ID: 15916969
[TBL] [Abstract][Full Text] [Related]
27. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes.
Krampera M; Tavecchia L; Benedetti F; Nadali G; Pizzolo G
Haematologica; 2000 Jul; 85(7):675-9. PubMed ID: 10897117
[TBL] [Abstract][Full Text] [Related]
28. Induction of proliferation in vitro of resting human natural killer cells: IL 2 induces into cell cycle most peripheral blood NK cells, but only a minor subset of low density T cells.
London L; Perussia B; Trinchieri G
J Immunol; 1986 Dec; 137(12):3845-54. PubMed ID: 3491151
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
[TBL] [Abstract][Full Text] [Related]
30. The involvement of T lymphocytes in the pathogenesis of endometriotic tissues overgrowth in women with endometriosis.
Szyllo K; Tchorzewski H; Banasik M; Glowacka E; Lewkowicz P; Kamer-Bartosinska A
Mediators Inflamm; 2003 Jun; 12(3):131-8. PubMed ID: 12857596
[TBL] [Abstract][Full Text] [Related]
31. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
32. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
Chen W; Chan AS; Dawson AJ; Liang X; Blazar BR; Miller JS
Biol Blood Marrow Transplant; 2005 Jan; 11(1):23-34. PubMed ID: 15625541
[TBL] [Abstract][Full Text] [Related]
33. Altered phenotype of natural killer cell subsets after haploidentical stem cell transplantation.
Schulze A; Schirutschke H; Oelschlägel U; Schmitz M; Füssel M; Wassmuth R; Ehninger G; Bornhäuser M; Platzbecker U
Exp Hematol; 2008 Apr; 36(4):378-89. PubMed ID: 18261840
[TBL] [Abstract][Full Text] [Related]
34. Progression of natural immunity during one-year treatment of residual disease in neuroblastoma patients with high doses of interleukin-2 after autologous bone marrow transplantation.
Martí F; Pardo N; Peiró M; Bertran E; Amill B; García J; Cubells J; Rueda F
Exp Hematol; 1995 Dec; 23(14):1445-52. PubMed ID: 8542930
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous delayed hypersensitivity, T cell subsets, and IL-2 secretion in patients with peripheral vascular disease.
Ulrich F; Johnson WC; Rudders RA
J Clin Lab Immunol; 1985 Nov; 18(3):107-12. PubMed ID: 3878884
[TBL] [Abstract][Full Text] [Related]
36. Ranitidine for prevention of postoperative suppression of delayed hypersensitivity.
Nielsen HJ; Moesgaard F; Kehlet H
Am J Surg; 1989 Mar; 157(3):291-4. PubMed ID: 2919733
[TBL] [Abstract][Full Text] [Related]
37. Comparison of the effects of SAG-M and whole-blood transfusions on postoperative suppression of delayed hypersensitivity.
Nielsen HJ; Hammer JH; Moesgaard F; Kehlet H
Can J Surg; 1991 Apr; 34(2):146-50. PubMed ID: 2025803
[TBL] [Abstract][Full Text] [Related]
38. The effect of selenium supplementation on DTH skin responses in healthy North American men.
Hawkes WC; Hwang A; Alkan Z
J Trace Elem Med Biol; 2009; 23(4):272-80. PubMed ID: 19747623
[TBL] [Abstract][Full Text] [Related]
39. Effect of ranitidine on soluble interleukin 2 receptors and CD8 molecules in surgical patients.
Nielsen HJ; Mynster T; Jensen S; Hammer J; Nielsen H
Br J Surg; 1994 Dec; 81(12):1747-51. PubMed ID: 7827929
[TBL] [Abstract][Full Text] [Related]
40. Effect of ranitidine and low-dose interleukin-2 in vitro on NK-cell activity in peripheral blood from patients with liver metastases from colorectal cancer.
Nielsen HJ; Moesgaard F; Hammer JH
Eur J Surg Oncol; 1995 Oct; 21(5):526-30. PubMed ID: 7589599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
